SINGAPORE PAINCARE HOLDINGS LIMITED (FRQ) Fair Value & Analysis
Healthcare · SG · Market cap 10.3M SGD
Fair value as of: Aug 13, 2026
From 13 valuation models · updated 4 days ago
Fair value updated Aug 13, 2026, revised from 0.0709 SGD to 0.0710 SGD (+0.1%) since Aug 9, 2026. Share price +15.6% over the past month.
A solid business, currently priced close to our fair value.
What matters now
- The price sits close to our fair value, market and models broadly agree here, little valuation tension.
- Our model range runs from 0.0553 SGD (bear) to 0.0817 SGD (bull), base 0.0710 SGD. The closer the price sits to the lower half, the larger the margin of safety.
- Quality 59/100 (solid quality) with medium evidence: read the verdict with care.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range 0.0600 SGD – 0.2309 SGD · fair‑value band 0.0553 SGD – 0.0817 SGD · the 0.0740 SGD price screens above the 0.0710 SGD fair value. Dashed = 300-day average. As of Aug 13, 2026.
Analysis
SINGAPORE PAINCARE HOLDINGS LIMITED (FRQ) currently trades at 0.0740 SGD, while our model-based Fair Value estimate is 0.0710 SGD, implying the stock looks roughly 4.1% fairly valued today. The Quality Score stands at 59/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).
Over the trailing twelve months, SINGAPORE PAINCARE HOLDINGS LIMITED generated revenue of 26.6M SGD at a net margin of -18.4%. Revenue declined 2.9% year over year. It earns a return on equity of -21.8%. Fundamentals as of Aug 13, 2026
Our scenario range runs from 0.0553 SGD (bear case) to 0.0817 SGD (bull case); at 0.0740 SGD, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 54% below its 52-week high and 23% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -14% fair-value upside, at -4%, FRQ screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 13 models by family
Widest divergence: Multiples (0.4800 SGD) versus Asset-Based (0.0700 SGD). Highest evidence: Growth DCF (80).
Notify me when FRQ reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 58 · Market factors (momentum, volatility) 26
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Singapore Paincare Holdings Limited, an investment holding company, operates medical clinics in Singapore. It operates general practitioner clinics, specialist clinics, traditional Chinese medicine centers, and physiotherapy centers for pain screening and treatments, cancer pain therapy, pharmacotherapy, and cognitive behavioral therapy.
Full company description
Singapore Paincare Holdings Limited, an investment holding company, operates medical clinics in Singapore. It operates general practitioner clinics, specialist clinics, traditional Chinese medicine centers, and physiotherapy centers for pain screening and treatments, cancer pain therapy, pharmacotherapy, and cognitive behavioral therapy. The company was founded in 2007 and is based in Singapore.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2020 – FY2025 · reported fiscal years
SINGAPORE PAINCARE HOLDINGS LIMITED reported revenue of 26.9M SGD in FY2024 versus 9.6M SGD in FY2020, a compound +29.2%/yr. Reported net income was −4.0M SGD in FY2025.
Watch FRQ: get an alert when its fair value changes →
Peer Group
Medical Care Facilities · 267 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Care Facilities median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc HCA | $414.59 | $547.67 | +32% |
| Fresenius SE FRE | €46.82 | €32.15 | -31% |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 235.00 SAR | 112.37 SAR | -52% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.67 SGD | 1.44 SGD | -46% |
| Tenet Healthcare Corporation THC | $266.79 | $330.25 | +24% |
| Rede D'Or São Luiz S.A RDOR3 | R$33.97 | R$47.31 | +39% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,565 | ₹2,955 | -65% |
| Aier Eye Hospital Group 300015 | ¥8.87 | ¥7.67 | -14% |
| Max Healthcare Institute Limited MAXHEALTH | ₹1,008 | ₹284.87 | -72% |
| Bangkok Dusit Medical Services Public Company BDMS | 19.70 THB | 18.57 THB | -6% |
Compare SINGAPORE PAINCARE HOLDINGS LIMITED with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is SINGAPORE PAINCARE HOLDINGS LIMITED (FRQ) overvalued or undervalued?
What is the fair value of FRQ?
What is the quality score of FRQ?
What is the revenue of SINGAPORE PAINCARE HOLDINGS LIMITED (FRQ)?
What is the net profit margin of FRQ?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track SINGAPORE PAINCARE HOLDINGS LIMITED and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.